Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors
Thiem, Alexander, Schummer, Patrick, Ueberschaar, Simon, Kerstan, Andreas, Kneitz, Hermann, Schrama, David, Appenzeller, Silke, Meierjohann, Svenja, Schilling, Bastian, Goebeler, Matthias, Gesierich,Language:
english
Journal:
Melanoma Research
DOI:
10.1097/CMR.0000000000000458
Date:
May, 2018
File:
PDF, 173 KB
english, 2018